Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cyclezyme AB's book value per share for the quarter that ended in Mar. 2026 was kr2.67.
During the past 12 months, Cyclezyme AB's average Book Value Per Share Growth Rate was 30.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 57.00% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 190.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Cyclezyme AB was 544.60% per year. The lowest was 57.00% per year. And the median was 150.60% per year.
Cyclezyme AB's current price is kr28.10. Its book value per share for the quarter that ended in Mar. 2026 was kr2.67. Hence, today's PB Ratio of Cyclezyme AB is 10.52.
During the past 6 years, the highest P/B Ratio of Cyclezyme AB was 10.56. The lowest was 4.51. And the median was 6.65.
Warning Sign:
Cyclezyme AB stock PB Ratio (=9.81) is close to 2-year high of 9.88.
Cyclezyme AB (XSAT:CYCLE) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Cyclezyme AB Book Value per Share Related Terms
Cyclezyme AB Book Value per Share Historical Data
* Premium members only.
The historical data trend for Cyclezyme AB's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSAT:CYCLE vs LIN, SHW, ECL: Book Value per Share Comparison
For the Specialty Chemicals subindustry, Cyclezyme AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cyclezyme AB PB Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Cyclezyme AB's PB Ratio distribution charts can be found below:
* The bar in red indicates where Cyclezyme AB's PB Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cyclezyme AB (XSAT:CYCLE) has a Book Value per Share of kr2.67 as of Mar. 2026. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Cyclezyme AB and its competitors.
Is Cyclezyme AB's Book Value per Share too high?
Cyclezyme AB's current Book Value per Share is kr2.67. Overall, Cyclezyme AB has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Cyclezyme AB's Book Value per Share compare to LIN and SHW?
Cyclezyme AB's Book Value per Share of kr2.67 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Chemicals company?
A good Book Value per Share depends on the Chemicals industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Cyclezyme AB and its competitors. Cyclezyme AB's current Book Value per Share is kr2.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cyclezyme AB stock overvalued right now?
Cyclezyme AB (XSAT:CYCLE) has a current Book Value per Share of kr2.67. The current Book Value per Share is kr2.67. Cyclezyme AB's overall GF Score™ is 8/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Cyclezyme AB (XSAT:CYCLE), the current Book Value per Share is kr2.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cyclezyme AB is a Sweden-based company that has developed an enzymatic platform focused on producing enzymes for green biochemical processes. This platform utilizes biotechnological methods to identify and improve enzymes capable of converting e.g. PET-based plastic materials for new building blocks. The company enables careful experiments and analyses of the behavior of different enzymes in the breakdown of e.g. PET material. The company refines its enzymes and also optimizes the processes for plastic recycling by combining experimental data with data analysis.
8GF Score
Get the complete analysis for XSAT:CYCLE
Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:CYCLE has been successfully added to your 
